Marimed (MRMD) Equity Ratio (2016 - 2025)
Marimed (MRMD) has disclosed Equity Ratio for 15 consecutive years, with 0.26 as the latest value for Q3 2025.
- On a quarterly basis, Equity Ratio fell 17.17% to 0.26 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.26, a 17.17% decrease, with the full-year FY2024 number at 0.28, down 20.65% from a year prior.
- Equity Ratio was 0.26 for Q3 2025 at Marimed, down from 0.28 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.43 in Q2 2023 to a low of 0.16 in Q1 2021.
- A 5-year average of 0.32 and a median of 0.32 in 2024 define the central range for Equity Ratio.
- Peak YoY movement for Equity Ratio: surged 25693.97% in 2021, then decreased 24.42% in 2024.
- Marimed's Equity Ratio stood at 0.29 in 2021, then grew by 27.8% to 0.38 in 2022, then dropped by 5.33% to 0.36 in 2023, then dropped by 20.65% to 0.28 in 2024, then decreased by 6.59% to 0.26 in 2025.
- Per Business Quant, the three most recent readings for MRMD's Equity Ratio are 0.26 (Q3 2025), 0.28 (Q2 2025), and 0.28 (Q1 2025).